The store will not work correctly when cookies are disabled.
7-[3-(3-Methoxy-phenyl)-4,5-dihydro-isoxazol-5-ylmethoxy]-4-methyl-chromen-2-one
ID: ALA4785477
PubChem CID: 162668157
Max Phase: Preclinical
Molecular Formula: C21H19NO5
Molecular Weight: 365.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc(C2=NOC(COc3ccc4c(C)cc(=O)oc4c3)C2)c1
Standard InChI: InChI=1S/C21H19NO5/c1-13-8-21(23)26-20-11-16(6-7-18(13)20)25-12-17-10-19(22-27-17)14-4-3-5-15(9-14)24-2/h3-9,11,17H,10,12H2,1-2H3
Standard InChI Key: LTSFMVGMKOBXRT-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
7.9683 -8.7208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9671 -9.5403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6752 -9.9493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6734 -8.3119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3820 -8.7172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3827 -9.5362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0913 -9.9433 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7995 -9.5325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7948 -8.7103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0857 -8.3070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0814 -7.4898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5088 -9.9383 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2591 -9.9484 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5517 -9.5392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8437 -9.9472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1008 -9.6166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5535 -10.2234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9616 -10.9315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7610 -10.7621 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7440 -10.1370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4130 -9.3886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6011 -9.3023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1194 -9.9635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4553 -10.7131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2662 -10.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2697 -8.5553 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7509 -7.8948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 5 1 0
10 11 1 0
8 12 2 0
2 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 15 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
17 20 1 0
22 26 1 0
26 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 365.39 | Molecular Weight (Monoisotopic): 365.1263 | AlogP: 3.68 | #Rotatable Bonds: 5 |
Polar Surface Area: 70.26 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.42 | CX LogP: 3.51 | CX LogD: 3.51 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.65 | Np Likeness Score: -0.56 |
References
1. Lingaraju GS,Balaji KS,Jayarama S,Anil SM,Kiran KR,Sadashiva MP. (2018) Synthesis of new coumarin tethered isoxazolines as potential anticancer agents., 28 (23-24): [PMID:30396758] [10.1016/j.bmcl.2018.10.046] |